Advisornet Financial’s Neurocrine Biosciences NBIX Stock Holding History

Advisornet Financial’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18K	Hold	7	–	–	﹤0.01%	2002
2026 Q1	$922	Sell	7 -4	-36%	-$531	﹤0.01%	2029
2025 Q4	$1.56K	Buy	11 +5	+83%	+$724	﹤0.01%	1935
2025 Q3	$842	Hold	6	–	–	﹤0.01%	1990
2025 Q2	$754	Buy	6 +2	+50%	+$229	﹤0.01%	1986
2025 Q1	$442	Hold	4	–	–	﹤0.01%	1981
2024 Q4	$546	Sell	4 -18	-82%	-$2.23K	﹤0.01%	1763
2024 Q3	$2.54K	Hold	22	–	–	﹤0.01%	1709
2024 Q2	$3.03K	Hold	22	–	–	﹤0.01%	1553
2024 Q1	$3.03K	Sell	22 -6	-21%	-$819	﹤0.01%	1530
2023 Q4	$3.69K	Buy	28 +24	+600%	+$2.76K	﹤0.01%	1555
2023 Q3	$450	Hold	4	–	–	﹤0.01%	2009
2023 Q2	$377	Buy	4 +1	+33%	+$98	﹤0.01%	2109
2023 Q1	$304	Buy	3 +1	+50%	+$104	﹤0.01%	2182
2022 Q4	$239	Buy	+2	New	+$234	﹤0.01%	2183

Other funds holding NBIX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PBBUPS

PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Advisornet Financial's NBIX Position: Q2 2026 in Review

Advisornet Financial held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 7 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Advisornet Financial first reported a position in NBIX in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.69K in Q4 2023. 155 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Advisornet Financial held 7 shares of Neurocrine Biosciences worth $1.18K as of Q2 2026.
Advisornet Financial left its Neurocrine Biosciences share count unchanged in Q2 2026.
Neurocrine Biosciences made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #2002 holding.
Advisornet Financial first reported a position in Neurocrine Biosciences in Q4 2022 and has held it in 15 quarters since.
Advisornet Financial's Neurocrine Biosciences position peaked at $3.69K in Q4 2023.
155 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.